Aap Implantate AG
XETRA:AAQ1
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.18
1.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Aap Implantate AG
EPS (Diluted)
Aap Implantate AG
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Aap Implantate AG
XETRA:AAQ1
|
EPS (Diluted)
€0
|
CAGR 3-Years
12%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
EPS (Diluted)
€1
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
EPS (Diluted)
€0
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
EPS (Diluted)
€1
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
EPS (Diluted)
€6
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
9%
|
|
|
Sartorius AG
XETRA:SRT
|
EPS (Diluted)
€1
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
Aap Implantate AG
Glance View
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 109 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
See Also
What is Aap Implantate AG's EPS (Diluted)?
EPS (Diluted)
-0.4
EUR
Based on the financial report for Dec 31, 2024, Aap Implantate AG's EPS (Diluted) amounts to -0.4 EUR.
What is Aap Implantate AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
43%
Over the last year, the EPS (Diluted) growth was 64%. The average annual EPS (Diluted) growth rates for Aap Implantate AG have been 12% over the past three years , 43% over the past five years .